160 related articles for article (PubMed ID: 23205267)
1. Target proteins of ganoderic acid DM provides clues to various pharmacological mechanisms.
Liu J; Shimizu K; Tanaka A; Shinobu W; Ohnuki K; Nakamura T; Kondo R
Sci Rep; 2012; 2():905. PubMed ID: 23205267
[TBL] [Abstract][Full Text] [Related]
2. Lucidumol D, a new lanostane-type triterpene from fruiting bodies of Reishi (Ganoderma lingzhi).
Satria D; Amen Y; Niwa Y; Ashour A; Allam AE; Shimizu K
Nat Prod Res; 2019 Jan; 33(2):189-195. PubMed ID: 29457741
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationships of lanostane-type triterpenoids from Ganoderma lingzhi as α-glucosidase inhibitors.
Fatmawati S; Kondo R; Shimizu K
Bioorg Med Chem Lett; 2013 Nov; 23(21):5900-3. PubMed ID: 24070782
[TBL] [Abstract][Full Text] [Related]
4. Ergosterol Peroxide from the Egyptian Red Lingzhi or Reishi Mushroom, Ganoderma resinaceum (Agaricomycetes), Showed Preferred Inhibition of MCF-7 over MDA-MB-231 Breast Cancer Cell Lines.
El-Sherif NF; Ahmed SA; Ibrahim AK; Habib ES; El-Fallal AA; El-Sayed AK; Wahba AE
Int J Med Mushrooms; 2020; 22(4):389-396. PubMed ID: 32558503
[TBL] [Abstract][Full Text] [Related]
5. 5alpha-reductase inhibitory effect of triterpenoids isolated from Ganoderma lucidum.
Liu J; Kurashiki K; Shimizu K; Kondo R
Biol Pharm Bull; 2006 Feb; 29(2):392-5. PubMed ID: 16462054
[TBL] [Abstract][Full Text] [Related]
6. Lanostane triterpenoids with cytotoxic activities from the fruiting bodies of Ganoderma hainanense.
Ma QY; Luo Y; Huang SZ; Guo ZK; Dai HF; Zhao YX
J Asian Nat Prod Res; 2013 Nov; 15(11):1214-9. PubMed ID: 23909866
[TBL] [Abstract][Full Text] [Related]
7. Tubulin polymerization-stimulating activity of Ganoderma triterpenoids.
Kohno T; Hai-Bang T; Zhu Q; Amen Y; Sakamoto S; Tanaka H; Morimoto S; Shimizu K
J Nat Med; 2017 Apr; 71(2):457-462. PubMed ID: 28078535
[TBL] [Abstract][Full Text] [Related]
8. Natural products of the medicinal fungus Ganoderma lucidum: occurrence, biological activities, and pharmacological functions.
Shiao MS
Chem Rec; 2003; 3(3):172-80. PubMed ID: 12900937
[TBL] [Abstract][Full Text] [Related]
9. [Triterpenoids from Ganoderma theaecolum].
Liu LY; Kang J; Wu CH; Li Y; Chen RY
Zhongguo Zhong Yao Za Zhi; 2016 Mar; 41(6):1075-1080. PubMed ID: 28875673
[TBL] [Abstract][Full Text] [Related]
10. Anti-cancer Effects of a Neutral Triterpene Fraction from Ganoderma lucidum and its Active Constituents on SW620 Human Colorectal Cancer Cells.
Li P; Liu L; Huang S; Zhang Y; Xu J; Zhang Z
Anticancer Agents Med Chem; 2020; 20(2):237-244. PubMed ID: 31749435
[TBL] [Abstract][Full Text] [Related]
11. Triterpenes from the spores of Ganoderma lucidum and their cytotoxicity against meth-A and LLC tumor cells.
Min BS; Gao JJ; Nakamura N; Hattori M
Chem Pharm Bull (Tokyo); 2000 Jul; 48(7):1026-33. PubMed ID: 10923835
[TBL] [Abstract][Full Text] [Related]
12. Network pharmacology analysis of the anti-cancer pharmacological mechanisms of Ganoderma lucidum extract with experimental support using Hepa1-6-bearing C57 BL/6 mice.
Zhao RL; He YM
J Ethnopharmacol; 2018 Jan; 210():287-295. PubMed ID: 28882624
[TBL] [Abstract][Full Text] [Related]
13. Improved Production and Antitumor Properties of Triterpene Acids from Submerged Culture of Ganoderma lingzhi.
Wang XL; Ding ZY; Liu GQ; Yang H; Zhou GY
Molecules; 2016 Oct; 21(10):. PubMed ID: 27775633
[TBL] [Abstract][Full Text] [Related]
14. Flavonoids isolated from Caribbean propolis show cytotoxic activity in human cancer cell lines.
Acikelli AH; Gustmann S; Bardenheuer W; Klein J; Dembinski U; Kohl B; Yip KT; Nazif A; Stoll R; Strumberg D; Díaz-Carballo D
Int J Clin Pharmacol Ther; 2013 Jan; 51(1):51-3. PubMed ID: 23259999
[No Abstract] [Full Text] [Related]
15. Distinguishing commercially grown Ganoderma lucidum from Ganoderma lingzhi from Europe and East Asia on the basis of morphology, molecular phylogeny, and triterpenic acid profiles.
Hennicke F; Cheikh-Ali Z; Liebisch T; Maciá-Vicente JG; Bode HB; Piepenbring M
Phytochemistry; 2016 Jul; 127():29-37. PubMed ID: 27044336
[TBL] [Abstract][Full Text] [Related]
16. Anti-microtubule activity of tubeimoside I and its colchicine binding site of tubulin.
Ma R; Song G; You W; Yu L; Su W; Liao M; Zhang Y; Huang L; Zhang X; Yu T
Cancer Chemother Pharmacol; 2008 Sep; 62(4):559-68. PubMed ID: 18030471
[TBL] [Abstract][Full Text] [Related]
17. Ganoderic acid DM: anti-androgenic osteoclastogenesis inhibitor.
Liu J; Shiono J; Shimizu K; Kukita A; Kukita T; Kondo R
Bioorg Med Chem Lett; 2009 Apr; 19(8):2154-7. PubMed ID: 19289282
[TBL] [Abstract][Full Text] [Related]
18. Ganodermataceae: natural products and their related pharmacological functions.
Zhou X; Lin J; Yin Y; Zhao J; Sun X; Tang K
Am J Chin Med; 2007; 35(4):559-74. PubMed ID: 17708623
[TBL] [Abstract][Full Text] [Related]
19. Accessing biological actions of Ganoderma secondary metabolites by in silico profiling.
Grienke U; Kaserer T; Pfluger F; Mair CE; Langer T; Schuster D; Rollinger JM
Phytochemistry; 2015 Jun; 114():114-24. PubMed ID: 25457486
[TBL] [Abstract][Full Text] [Related]
20. Immunochromatographic strip assay for detection of bioactive Ganoderma triterpenoid, ganoderic acid A in Ganoderma lingzhi.
Sakamoto S; Kikkawa N; Kohno T; Shimizu K; Tanaka H; Morimoto S
Fitoterapia; 2016 Oct; 114():51-55. PubMed ID: 27575328
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
